Tomocube Inc
475960
Company Profile
Business description
Tomocube Inc is a technology-based company that provides solutions in life science research and diagnosis. The group's Core technology, holotomography, is a non-invasive imaging technique that uses light diffraction to acquire three-dimensional images of cells and tissues without dyeing or labeling. Its products and applications are Holotomography includes HT-X1, HT-X1, and HT-2H, TomoAnalysis, Accessories Cell biology, Regenerative medicine, 3D biology, Immunology, and LLPS.
Contact
155 Shinsung-ro
4th floor
Yuseong-gu
Daejeon34109
KORT: +82 428631100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,393.00 | 19.30 | 0.21% |
| CAC 40 | 8,206.07 | 17.48 | 0.21% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,990.54 | 310.57 | 1.37% |
| Nikkei 225 | 49,648.61 | 463.11 | 0.94% |
| NZX 50 Index | 13,324.48 | 20.48 | -0.15% |
| S&P 500 | 6,735.13 | 71.12 | 1.07% |
| S&P/ASX 200 | 9,091.50 | 15.60 | 0.17% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |